Current status and future prospects of drug delivery systems

Methods in Molecular Biology

Volumn 1141, Issue , 2014, Pages 1-56

  Jain, Kewal K ^a  

^a NONE

Author keywords

Cell therapy; Controlled release; Drug delivery systems; Drug formulations; Gene therapy; Nanobiotechnology; Nanoparticles; Personalized medicine; Protein peptide delivery; Routes of drug administration; Targeted drug delivery

Indexed keywords

AVIDIN; BIOTIN; CHITOSAN NANOPARTICLE; COLLAGEN; DRUG CARRIER; DRUG VEHICLE; GLASS LIKE SUGAR MATRIX; LIPOSOME; MACROGOL; MICROSPHERE; NANOPARTICLE; NANOSPONGE; POLYMER; PRODRUG; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

BLOOD BRAIN BARRIER; BUCCAL DRUG ADMINISTRATION; CARDIOVASCULAR SYSTEM; CELL BASED GENE THERAPY; CELL THERAPY; CENTRAL NERVOUS SYSTEM; CHRONOPHARMACOLOGY; CONTROLLED DRUG RELEASE; CONTROLLED RELEASE FORMULATION; CONTROLLED RELEASE MICROCHIP; DRUG DELIVERY DEVICE; DRUG DELIVERY SYSTEM; DRUG DEVELOPMENT; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; DRUG SOLUBILITY; DRUG TARGETING; DRY POWDER; ERYTHROCYTE; GENE THERAPY; HUMAN; IMPLANT DELIVERY DEVICE; IN VIVO STUDY; INHALER; INTRAARTERIAL DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; INTRAPULMONARY DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MACROMOLECULE; MEDICATION COMPLIANCE; MICELLE; MUCOSAL DRUG ADMINISTRATION; NANOTECHNOLOGY; NONHUMAN; ORAL DRUG ADMINISTRATION; PARENTERAL DRUG ADMINISTRATION; PERSONALIZED MEDICINE; PHARMACOGENETICS; PHARMACOGENOMICS; PHARMACOKINETICS; PHARMACOPROTEOMICS; PROTEOMICS; PUMP; RECTAL DRUG ADMINISTRATION; SHELF LIFE; SOFTGEL FORMULATION; SUBCUTANEOUS DRUG ADMINISTRATION; SUBLINGUAL DRUG ADMINISTRATION; SUSTAINED DRUG RELEASE; TIMED DRUG RELEASE; TRANSDERMAL DRUG ADMINISTRATION;

EID: 84929940786     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-0363-4_1     Document Type: Chapter

References (38)

1. Jain KK (2014) Transdermal drug delivery: technologies, markets and companies. Jain PharmaBiotech Publications, Basel, pp 1–280.
2. Donnelly RF, Garland MJ, Alkilani AZ (2014) Microneedle-iontophoresis combinations for enhanced transdermal drug delivery, Chapter 7. In: Jain KK (ed) Drug delivery system, Methods Mol Biol. Springer, New York.
3. Singh RM, Kumar A, Pathak K (2013) Mucoadhesive in situ nasal gelling drug delivery systems for modulated drug delivery. Expert Opin Drug Deliv 10:115–130.
4. Gizurarson S (2012) Anatomical and histological factors affecting intranasal drug and vaccine delivery. Curr Drug Deliv 9:566–582.
5. Krishnaiah YS, Khan MA (2012) Strategies of targeting oral drug delivery systems to the colon and their potential use for the treatment of colorectal cancer. Pharm Dev Technol 17: 521–540.
6. Salomon JJ, Ehrhardt C (2012) Organic cation transporters in the blood-air barrier: expression and implications for pulmonary drug delivery. Ther Deliv 3(6):735–747.
7. Li HY, Zhang F (2012) Preparation of nanoparticles by spray-drying and their use for effi cient pulmonary drug delivery. Methods Mol Biol 906:295–301.
8. Beck-Broichsitter M, Dalla-Bona AC, Kissel T, Seeger W, Schmehl T (2014) Polymer nanoparticle- based controlled pulmonary drug delivery, Chapter 8. In: Jain KK (ed) Drug delivery system, Methods Mol Biol. Springer, New York.
9. Jain KK (2011) Applications of biotechnology in cardiovascular therapeutics. Springer Science, New York.
10. Jain KK (2014) Cardiovascular drug delivery: technologies, markets and companies. Jain PharmaBiotech Publications, Basel, pp 1–268.
11. Jain KK (ed) (2010) Drug delivery to the central nervous system. Humana, New York.
12. Jain KK (2013) Applications of biotechnology in neurology. Springer, New York.
13. Jain KK (2014) Drug delivery in CNS disorders: technologies, markets and companies. Jain PharmaBiotech Publications, Basel, pp 1–360.
14. Jain KK (2012) Nanobiotechnology-based strategies for crossing the blood-brain barrier. Nanomedicine 7:1225–1233.
15. Guarnieri D, Muscetti O, Netti PA (2014) A method for evaluating nanoparticle transport through the blood brain barrier in vitro, Chapter 12. In: Jain KK (ed) Drug delivery system, Methods Mol Biol. Springer, New York.
16. De Andres J et al (2014) Intrathecal delivery of analgesics, Chapter 16. In: Jain KK (ed) Drug delivery system, Methods Mol Biol. Springer, New York.
17. Gupta S, Batra S, Jain M (2014) Antibody labeling with radioiodine and radiometals, Chapter 9. In: Jain KK (ed) Drug delivery system, Methods Mol Biol. Springer, New York.
18. Jain KK (2014) Gene therapy: technologies, markets and companies. Jain PharmaBiotech Publications, Basel, pp 1–665.
19. Cummins J, Cronin M, van Pijkeren JP, Gahan C, Tangney M (2014) Bacterial systems for gene delivery to systemic tumours, Chapter 13. In: Jain KK (ed) Drug delivery system, Methods Mol Biol. Springer, New York.
20. Cullis PR, Ramsay E (2014) Microfl uidicbased manufacture of siRNA-lipid nanoparticles for therapeutic applications, Chapter 6. In: Jain KK (ed) Drug delivery system, Methods Mol Biol. Springer, New York.
21. Gao JQ, Hu UL (2014) Stem cells as carriers for cancer gene therapy, Chapter 5. In: Jain KK (ed) Drug delivery system, Methods Mol Biol. Springer, New York.
22. Muzykantov VR (2010) Drug delivery by red blood cells: vascular carriers designed by mother nature. Expert Opin Drug Deliv 7:403–427.
23. Boopathy AV, Davis ME (2014) Self assembling peptide-based delivery of therapeutics for myocardial infarction, Chapter 10. In: Jain KK (ed) Drug delivery system, Methods Mol Biol. Springer, New York.
24. Farra R, Sheppard NF Jr, McCabe L et al (2012) First-in-human testing of a wirelessly controlled drug delivery microchip. Sci Transl Med 4(122):122ra21.
25. Nguyen NT, Shaegh SA, Kashaninejad N, Phan DT (2013) Design, fabrication and characterization of drug delivery systems based on lab-on-a-chip technology. Adv Drug Deliv Rev 65(11–12):1403–1419, pii: S0169-409X(13)00127-0.
26. Castle J (2014) Ultrasound-directed sitespecifi c gene delivery, Chapter3. In: Jain KK (ed) Drug delivery system, Methods Mol Biol. Springer, New York.
27. Jain KK (2014) Nanobiotechnology: applications, markets and companies. Jain PharmaBiotech Publications, Basel, pp 1–774.
28. Yamada Y, Harashima H (2014) Methodology for screening mitochondrial fusogenic envelopes for use in mitochondrial drug delivery, Chapter2. In: Jain KK (ed) Drug delivery system, Methods Mol Biol. Springer, New York.
29. Mishra S, De A, Mozumdar S (2014) Synthesis of a thermoresponsive polymer for drug delivery, Chapter 4. In: Jain KK (ed) Drug delivery system, Methods Mol Biol. Springer, New York.
30. Tajmir-Riahi HA, Nafi si S, Sanyakamdhorn S et al (2014) Applications of chitosan nanoparticles in drug delivery, Chapter 11. In: Jain KK (ed) Drug delivery system, Methods Mol Biol. Springer, New York.
31. Malhotra M, Tomaro-Duchesneau C, Saha S, Prakash S (2014) Intranasal delivery of chitosansiRNA nanoparticle formulation to the brain, Chapter 15. In: Jain KK (ed) Drug delivery system, Methods Mol Biol. Springer, New York.
32. Torne S, Darandale S, Vavia P et al (2013) Cyclodextrin-based nanosponges: effective nanocarrier for Tamoxifen delivery. Pharm Dev Technol 18:619–625.
33. Lesch HP, Kaikkonen MU, Pikkarainen JT, Ylä-Herttuala S (2010) Avidin-biotin technology in targeted therapy. Expert Opin Drug Deliv 7:551–564.
34. De A, Mishra S, Garg S, Mozumdar S (2014) Synthesis of a smart nanovehicle for targeting liver, Chapter 14. In: Jain KK (ed) Drug delivery system, Methods Mol Biol. Springer, New York.
35. Jain KK (2014) Personalized medicine: scientifi c and commercial aspects. Jain PharmaBiotech Publications, Basel, pp 1–860.
36. Jain KK (2009) A textbook of personalized medicine. Springer Science, New York.
37. Zhang H, Wang G, Yang H (2011) Drug delivery systems for differential release in combination therapy. Expert Opin Drug Deliv 8:171–190.
38. Jain KK (2014) Drug delivery in cancer: technologies, markets and companies. Jain PharmaBiotech Publications, Basel, pp 1–668.